Progression to CD: indeterminate colitis vs IBDU

The retrieved excerpts do not directly compare rates of progression to [Crohn's disease](https://crohnsology.org (patient sites: crohnz.org)/) between "indeterminate colitis" (a post-colectomy pathological diagnosis) and "IBD unclassified" (a pre-colectomy clinical diagnosis). The terms are used inconsistently across the excerpts, and no single study contrasts the two groups head-to-head. What is reported is that among patients labeled with indeterminate colitis, only a minority eventually develop Crohn's disease while the majority behave like ulcerative colitis, and reclassification to a definite diagnosis is common over time ^1,2. ^1–5

What is known:

• A small minority of indeterminate colitis patients eventually develop Crohn's disease, while the majority behave like ulcerative colitis on follow-up and after pouch surgery. ¹
• In one cohort, 72.5% of indeterminate colitis patients received a definite diagnosis of Crohn's disease or ulcerative colitis during follow-up, with an 80% cumulative probability of reclassification at 8 years; Crohn's diagnosis was more likely with fever at onset, segmental endoscopic lesions, extra-intestinal complications, or current smoking. ²
• When made carefully, the indeterminate colitis diagnosis is associated with a low incidence of conversion to Crohn's disease over the long term. ³
• Terminology differs: indeterminate colitis has been defined as a post-colectomy pathological diagnosis when definitive Crohn's/UC features are absent, whereas IBD unclassified is described separately in a case-control study. ^4,5

What is unknown / caveats:

• Excerpts use 'indeterminate colitis' and 'IBD unclassified' with differing/overlapping definitions, so a clean comparison cannot be extracted
• No excerpt reports a head-to-head comparison of progression-to-Crohn's rates between the two labels
• Progression figures come from single-cohort/pathology series, not comparative studies
• The evidence does not establish whether progression to Crohn's disease differs between indeterminate colitis and IBD unclassified.

References

1. Talbot IC. Indeterminate colitis: a pathologist's view. Dig Liver Dis. 2005;37(9):713-5. PMID: 15919251.

2. Meucci G, Bortoli A, Riccioli FA, Girelli CM, Radaelli F, Rivolta R, Tatarella M. Frequency and clinical evolution of indeterminate colitis: a retrospective multi-centre study in northern Italy. GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali). Eur J Gastroenterol Hepatol. 1999;11(8):909-13. PMID: 10514127.

3. Gramlich T, Delaney CP, Lynch AC, Remzi FH, Fazio VW. Pathological subgroups may predict complications but not late failure after ileal pouch-anal anastomosis for indeterminate colitis. Colorectal Dis. 2003;5(4):315-9. PMID: 12814408.

4. Lin J, Cao Q, Zhang J, Li Y, Shen B, Zhao Z, Chinnaiyan AM, Bronner MP. MicroRNA expression patterns in indeterminate inflammatory bowel disease. Mod Pathol. 2013;26(1):148-54. PMID: 22899284.

5. [No authors listed]. Clinical features of inflammatory bowel disease unclassified: a case-control study. BMC Gastroenterol. 2024;24(1):105. PMID: 38481157.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.